EUVIMEDEUVIMED entdecken
Crossref

Differences in Placental Pathology Between COVID‐19‐Induced Preeclampsia‐Like Syndrome and True Preeclampsia

Berta Serrano iD, Marta Garrido iD, Erika Bonacina iD, Itziar Garcia-Ruiz iD, Pablo Garcia-Manau iD, Paula Garcia-Aguilar iD, Nuria Fernández-Hidalgo iD, Elena Sulleiro iD, Laura Castillo-Ribelles iD, Nerea Maiz iD, Ester Del Barco iD, Elena Carreras und 2 weitere

Journal of Obstetrics and Gynaecology Research · 2026-11 · 52 (11)

DOI: 10.1111/jog.70576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 10.11.2026. Verfasst von Berta Serrano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Maternal-Fetal Medicine Research Group, Vall D'hebron Research Institute (VHIR), Vall D'hebron Barcelona Hospital Campus, Centres de Recerca de Catal…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta, COVID-19, Pregnancy Complications, Infectious. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Women with COVID‐19 may develop preeclampsia‐like syndrome, which shares some of the clinical features of preeclampsia (PE) but lacks its characteristic angiogenic imbalance (elevated soluble fms‐like tyrosine kinase‐1‐to‐placental growth factor ratio (sFlt‐1/PlGF ratio)), suggesting the absence of placental involvement. The aim of this study was to investigate whether pathological placental changes associated with PE, such as maternal vascular malperfusion (MVM), may be useful to discriminate true PE from COVID‐19‐induced PE‐like syndrome.

Methods

This is a prospective cohort study conducted from February 2020 to September 2021. Inclusion criteria were pregnancies with SARS‐CoV‐2 infection that met the diagnostic criteria for PE. Cases with a normal sFlt‐1/PlGF ratio (≤ 38) were classified as PE‐like syndrome and cases with an abnormal sFlt‐1/PlGF ratio were classified as true PE. A perinatal pathologist blinded to group allocation performed the placental histopathological examination for signs of MVM.

Results

During the study period, 106 pregnant women with severe COVID‐19 were admitted to the Intensive Care Unit. Among them, 15 (14.2%) met the diagnostic criteria for PE, and 11 placentas (73.3%) were available for histopathological examination. Of the 5 true PE cases, 80.0% had placentas with MVM. In contrast, none of the 6 PE‐like syndrome placentas met the MVM criteria.

Conclusions

The absence of MVM in PE‐like syndrome supports the initial evidence based on angiogenic factors: PE‐like syndrome and true PE are different conditions with similar clinical features but different etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPlacentaCOVID-19Pregnancy Complications, InfectiousHumansFemalePregnancyAdultProspective StudiesPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2angiogenic factorsmaternal vascular malperfusionpreeclampsia‐like syndrome

Substanzen

Placenta Growth FactorVascular Endothelial Growth Factor Receptor-1FLT1 protein, humanPGF protein, human

Autor:innen und Institutionen

  • Maternal-Fetal Medicine Research Group, Vall D'hebron Research Institute (VHIR), Vall D'hebron Barcelona Hospital Campus, Centres de Recerca de Catalunya (CERCA), Barcelona, Spain.
  • Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Vall d'.Hebron Hospital Universitari, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Department of Pathology, Vall D'hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Departament de Pediatria, D'obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Department of Infectous Diseases, Vall D'hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Microbiology, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain.

ORCID-Profile: Berta Serrano, Marta Garrido, Erika Bonacina, Itziar Garcia-Ruiz, Pablo Garcia-Manau, Paula Garcia-Aguilar, Nuria Fernández-Hidalgo, Elena Sulleiro, Laura Castillo-Ribelles, Nerea Maiz, Ester Del Barco, Anna Suy, Manel Mendoza

Zitieren

APA

Serrano, B., Garrido, M., Bonacina, E., Garcia-Ruiz, I., Garcia-Manau, P., Garcia-Aguilar, P., Fernández-Hidalgo, N., Sulleiro, E., Castillo-Ribelles, L., Maiz, N., Del Barco, E., Carreras, E., Suy, A., & Mendoza, M. (2026). Differences in Placental Pathology Between COVID‐19‐Induced Preeclampsia‐Like Syndrome and True Preeclampsia. Journal of Obstetrics and Gynaecology Research, 52(11). https://doi.org/10.1111/jog.70576

Vancouver

Serrano B, Garrido M, Bonacina E, Garcia-Ruiz I, Garcia-Manau P, Garcia-Aguilar P, et al. Differences in Placental Pathology Between COVID‐19‐Induced Preeclampsia‐Like Syndrome and True Preeclampsia. Journal of Obstetrics and Gynaecology Research. 2026;52(11). doi:10.1111/jog.70576

BibTeX
@article{Serrano2026,
  author = {Serrano, Berta and Garrido, Marta and Bonacina, Erika and Garcia-Ruiz, Itziar and Garcia-Manau, Pablo and Garcia-Aguilar, Paula and Fernández-Hidalgo, Nuria and Sulleiro, Elena and Castillo-Ribelles, Laura and Maiz, Nerea and Del Barco, Ester and Carreras, Elena and Suy, Anna and Mendoza, Manel},
  title = {Differences in Placental Pathology Between COVID‐19‐Induced Preeclampsia‐Like Syndrome and True Preeclampsia},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  volume = {52},
  number = {11},
  doi = {10.1111/jog.70576}
}
Kostenlos starten →